Different sling procedures for stress urinary incontinence: A lesson from 453 patients  by Luo, De-Yi et al.
Kaohsiung Journal of Medical Sciences (2014) 30, 139e145Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http: / /www.kjms-onl ine.comORIGINAL ARTICLEDifferent sling procedures for stress urinary
incontinence: A lesson from 453 patientsDe-Yi Luo, Kun-Jie Wang, Han-Chao Zhang, Yi Dai, Tong-Xing Yang,
Hong Shen*Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan,
PR ChinaReceived 15 April 2013; accepted 28 June 2013
Available online 15 October 2013KEYWORDS
Sling procedure;
Stress urinary
incontinence;
TVT;
TVT-O;
TVT-SConflict of Statement: The authors
* Corresponding author. Department
610041, PR China.
E-mail address: shen1177hx@163.c
1607-551X/$36 Copyright ª 2013, Kao
http://dx.doi.org/10.1016/j.kjms.201Abstract Several midurethral sling (MUS) procedures, such as tension-free vaginal tape
(TVT), TVT obturator (TVT-O), tension-free vaginal tape SECUR (TVT-S), and pubovaginal sling
(PVS), have been used for the treatment of female stress urinary incontinence (SUI); however,
which method is best for a particular patient group is not known. This study aimed to identify
the best rationale for choosing the optimal MUS procedure for each patient. In total, 453
consecutive female patients with SUI who were treated with MUSs in West China Hospital of
Sichuan University from September 2003 to September 2011 were enrolled in this study. All
the patients underwent comprehensive pre-, intra-, and postoperative evaluations, including
collection of demographic information, pelvic examination, and urodynamic testing, and
operation-related complications were recorded. The Incontinence Quality of Life question-
naire was also completed. Under local or general anesthesia, 105 cases were treated with
TVT, 243 with TVT-O, 90 with TVT-S, and 15 with PVS. Patients with different profiles in terms
of age, symptom duration, concomitant procedures, urodynamic parameters, and pelvic organ
prolapse (POP) quantification score were treated successfully; the body mass index did not
differ significantly among the various treatment options. The cure and improvement rates
were similar among the treatment groups: 97.14% (102/105) in TVT, 100% (243/243) in TVT-
O, 98.89% (89/90) in TVT-S, and 100% (15/15) in PVS. Only minor complications were experi-
enced by the patients. In conclusion, each MUS procedure was observed to be safe and effec-
tive in different subpopulations of patients, and the results suggest that appropriate patient
selection is crucial for the success of each MUS procedure.
Copyright ª 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.have no conflicts of interest relevant to this article.
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the TVT-O technique was similar to that described by deStress urinary incontinence (SUI) is a common health
problem, with the prevalence rate ranging from 12.8% to
46.0%. SUI has a major impact on the quality of life (QOL) of
many women, and it represents a major economic burden
globally [1]. Various therapeutic options are available to
alleviate this problem, and surgical correction is used for
women with SUI in whom conservative management stra-
tegies have failed [2].
The midurethral sling (MUS) is the most commonly per-
formed surgical treatment and has been considered as a gold
standard for treating patients with SUI [3]. The pubovaginal
sling (PVS) was described in the early 20th century and was
brought intowideclinical usebyDrsE.J.McGuireandB.Lytton
in the late 1970s [4]. Thereafter, the tension-free vaginal tape
(TVT) procedure was developed in 1996 by Dr U. Ulmsten and
colleagues [5]. In 2001, Dr E. Delorme [6] introduced the
outside-in transobturator tape (TOT) method, in which the
needle is penetrated through the skin to the vaginal anterior
wall, and in 2003, Dr J. de Leval [7] described the inside-out
TVT-obturator (TVT-O) method. In an attempt to minimize
postoperative complications further and reduce the need for
anesthesia, single-incision slings, such as tension-free vaginal
tape SECUR (TVT-S), have been developed.
Therefore, a broad spectrum of options exists for patients
with SUI who undergo surgical treatment. However, in clin-
ical practice, choosing themost appropriate sling therapy for
treating different groups of SUI patients is challenging. The
objective of this study was to summarize the associations
between patient conditions and the MUS procedure chosen.
Here,we reported the patient conditions that are considered
most appropriate for each MUS procedure, including TVT,
TVT-O, TVT-S (Johnson & Johnson Medical (China) Ltd,
Shanghai, China), and PVS, to ensure the best outcome.
Materials and methods
Design
The study was a retrospective cohort analysis and was
approved by the hospital ethics committee. Patient datawere
collectedfromthedatabaseof theUrologyClinicatWestChina
Hospital, Sichuan University (Chengdu, Sichuan, P.R. China),
from September 2003 through September 2011. All these pa-
tients underwent TVT, TVT-O, TVT-S, or PVS to treat SUI.
Participants
Female patients aged 18e85 years who had SUI or mixed
urinary incontinence (MUI) and underwent treatment with a
sling procedure were enrolled. Patients with pure urge in-
continence, overflow incontinence, or continuous inconti-
nence due to a neurological deficit and those with poorly
controlled diabetes and vaginal or urinary tract infection
were excluded from this study.
Procedure
All the procedures were performed by a single surgeon
(H.S.). During this study, the TVT technique used wassimilar to that described previously by Ulmsten et al. [5],
Leval [7], and the TVT-S technique was similar to that
described by Neuman [8].
The surgical technique for PVS was similar to that
described in the literature [9]. Briefly, the bladder neck
was exposed transvaginally, and PVSs 8e10 cm in length
were harvested from the anterior rectus sheath and sus-
pended using a zero polyglactin suture with a Kocher clamp
that was passed from the abdominal incision into the ret-
ropubic space and out from the vaginal incision. The suture
was finally pulled up into the abdominal incision. Cystos-
copy was performed to confirm no injury to the bladder or
urethra. The sling was sutured in place in the midline to the
bladder neck, and the sutures were then tied with no
tension over the rectus fascia. Incisions were closed using
absorbable sutures, and a Foley catheter was left in place.
Assessments
Baseline evaluations, including patient demographics,
medical and surgical histories, pelvic examination, and
urodynamic testing, were conducted. At the pretreatment
and 12-month postoperative visits, all the patients
completed the Chinese-translated forms of both the In-
continence Quality of Life (I-QOL) questionnaire [10] and
the Incontinence Visual Analogue Scale (I-VAS; 0, no in-
continence; 10, extremely severe incontinence). The Pelvic
Organ Prolapse Quantification System [11] was used for
pelvic examination. At the beginning of the pelvic exami-
nation, patients with a full bladder had a cough or Valsalva
leak test in the supine position. If there was no leak, the
test was repeated in the sitting and standing positions. If
there was any amount of urinary leakage during the test,
the patient was diagnosed with clinical SUI. Urodynamic
testing was performed according to the International
Continence Society standards [12].
Surgical results were evaluated 1 year postoperatively
by the cough stress test with a full bladder and symptom
questionnaire. The outcome of surgical treatment was
divided into three categories: cured, improved, and failed.
“Cured” indicated that patients had a negative cough stress
test and no urine leakage during stress. “Improved” indi-
cated that the patients had no urine leakage in the cough
stress test but may experience occasional urine leakage
during stress; occasional leakage neither infiuenced daily-
life activities nor required any further treatment. “Failed”
indicated that the patients had urine leakage in both the
cough stress test and during stress. At 1 year post-
operatively, the patients were asked to classify their global
satisfaction level as very satisfied, satisfied, or dissatisfied.
Both “very satisfied” and “satisfied” were considered to
indicate satisfied.
Operation time (from incision to closure), estimated
blood loss (calculated as the total volume to the volume of
prefilled water in the suction chamber), and perioperative
complications were recorded.
Statistical analysis
A statistical analysis was performed using SPSS version 17.0
for Windows (SPSS Inc., Chicago, IL, USA). Continuous
Sling procedure for SUI 141variables were presented as the mean  standard deviation
(SD), whereas categorical data were represented as the
number and percentage of all the patients. Nonparametric
data were presented as the median and interquartile
range. A descriptive analysis of each study variable was
performed, and postoperative changes were analyzed using
the paired t test or Wilcoxon signed rank test. Continuous
or ordinal variables were compared between the four
methods using a one-way analysis of variance or the Wil-
coxon ManneWhitney test according to the normality of
the distribution. Categorical variables were compared
using the Chi-square test/Fisher exact test. Nonparametric
data gathered using the I-QOL questionnaire were
compared using the KruskaleWallis test. The Bonferroni
correction was applied where necessary. Statistical signif-
icance was considered at p < 0.05 in all statistical
analyses.
Results
In total, 453 consecutive female patients with SUI under-
went a sling procedure and were enrolled retrospectively.
The patients were divided into four groups according to the
sling procedure as follows: TVT (nZ 105), TVT-O (nZ 243),
TVT-S (nZ 90), and PVS (nZ 15) groups. Patient conditions
and preoperative data are summarized in Table 1. Age,
symptom duration, percentage of patients with a concom-
itant procedure, urodynamic parameters, and POP quanti-
fication score were significantly different among the groups
(p  0.0139). The body mass index (BMI) was 21.8  2.6 kg/
m2 in this population of SUI patients and did not differ
significantly among the groups (p Z 0.1822).
Results of the I-QOL questionnaire are shown in Table 2.
Statistical significance was observed in pre- and post-
operative QOL scores of the four groups (p < 0.001). The
total score and scores of all three individual domains were
improved significantly at the postoperative evaluation
compared to baseline in all four groups (p < 0.05). The
postoperative improvement in total score was greatest in
the TVT group. In the preoperative evaluation, the TVT-S
group had the highest QOL score, whereas the PVS group
exhibited the lowest QOL score. Additionally, the patients
in the PVS group demonstrated the highest I-VAS, whereas
those in the TVT-S group exhibited the lowest I-VAS.
As shown in Table 3, under local or general anesthesia,
the mean operation time for the four groups was signifi-
cantly different (p < 0.001): TVT, 46.3 minutes (range,
30e60 minutes); TVT-O, 31.2 minutes (range, 25e45 mi-
nutes); TVT-S, 7.9 minutes (range, 7e15 minutes); and PVS,
101.6 minutes (range, 90e150 minutes). The operation time
for TVT-S was significantly shorter when compared with
TVT, TVT-O, and PVS.
The average amount of blood loss during the operation
also differed significantly (p < 0.001) among the four
groups: TVT, 35.4 mL (range, 30e50 mL); TVT-O, 23.2 mL
(range, 15e30 mL); TVT-S, 12.0 mL (range, 5e20 mL); and
PVS, 81.2 mL (range, 50e100 mL). The patients neither
suffered any adverse sequelae due to blood loss nor war-
ranted any treatment. As a routine procedure, a urine
catheter was maintained after each surgical procedure.
The postoperative indwelling catheterization time differed
significantly among the groups (p < 0.001): 1e4 days forTVT, 1e3 days for TVT-O, 1e2 days for TVT-S, and 5e49
days for PVS. All patients who underwent PVS were rec-
ommended to receive clean intermittent catheterization
until they could void normally, and the longest duration of
clean intermittent catheterization was 49 days. Difficulty in
voiding was not observed after the removal of the catheter.
Intra- and postoperative complications are shown in
Table 3. Bladder perforation was observed only in one pa-
tient during the TVT procedure. No urethral or vessel lesion
was found intraoperatively. Additionally, hematoma and
mesh tape exposure were not observed postoperatively. De
novo overactive bladder symptoms such as frequency, ur-
gent urination, and urge incontinence were found in three
patients with TVT (2.86%), five patients with TVT-O (2.06%),
two patients with TVT-S (2.22%), and one patient with PVS
(6.67%), and all these patients showed improvement after
the administration of anticholinergic agents. Urinary tract
infection was not observed in the TVT-S group post-
operatively, and its rate ranged from 0.41% to 13.33% in the
remaining three groups.
At the follow-up examination, the rate of cure and
improvement in patients was 95.14% (431 of 453) in the
entire cohort, 97.14% (102/105) for TVT, 100% (243/243) for
TVT-O, 98.89% (89/90) for TVT-S, and 100% (15/15) for PVS,
according to the assessment standard. No patients were
categorized as having a failed procedure in either the TVT-
O or the PVS group. As observed in Table 4, based on the
patient self-report of surgical satisfaction, 89.52% of TVT
patients were “very satisfied” or “satisfied” with the sur-
gical procedure; this number was significantly higher in the
other three groups: 98.77% in the TVT-O group, 95.56% in
the TVT-S group, and 100% in the PVS group.
Discussion
Sling surgery is considered the gold standard for the treat-
ment of SUI [3]. The placement of slings is technically easy,
the operation time is short, and the frequency of complica-
tions is low. Most importantly, the cure rates of slings are
between 70% and 90%, and they remain stable over time [13].
However, there is no consensus about whether a single
best surgery exists for all patients with all conditions. Many
factors should be considered when choosing the appro-
priate operation for SUI in an individual patient for ensuring
a favorable outcome or minimizing the risk of a poor
outcome or associated complications. The present study
identified important factors to consider when choosing
among the four sling procedures.
Since 2003, sling procedures, including TVT, TVT-O, TVT-
S, and PVS, have been used to treat patients with SUI in our
department, and we have selected different types of sling
procedures for different patients according to age, symp-
tom duration, percentage of women with a concomitant
procedure, urodynamic parameters, and POP quantification
score, which have been found to differ significantly be-
tween these groups. In the present study, the cure rate was
95.14% for the entire cohort, although one of the limita-
tions of this investigation is the relatively small number of
patients in the PVS group.
The effect of age on the outcomes of sling surgery is
relatively undefined. Hellberg et al. [14] have reported a
cure rate of 56% for patients aged > 75 years compared
Table 1 Preoperative characteristics of patients in the TVT, TVT-O, TVT-S, and PVS groups.
Variables TVT
(n Z 105)
TVT-O
(n Z 243)
TVT-S
(n Z 90)
PVS
(n Z 15)
p*
Age (y) 53.9  14.1
(18e80)
51.1  9.1
(33e82)
52.4  10.7
(25e69)
45.3  7.2
(39e58)
0.0139
BMI (kg/m2)a 24.1  2.0
(22.1e26.0)
20.4  2.6
(17.5e22.4)
20.2  2.2
(18.1e22.4)
22.7  2.3
(20.6e25.2)
0.1822
Symptom duration (y) 15.2  13.6
(0.5e50)
6.4  6.2
(0.5e35)
8.3  8.2
(0.2e20)
21.7  14.0
(3e32)
<0.0001
Incontinence type
Pure stress 80 (76.2) 181 (74.5) 63 (70) 8 (53.3)
Mixed 25 (23.8) 62 (25.5) 27 (30) 7 (46.7)
Concomitant procedure 5 (4.8) 26 (10.7) 2 (2.2) 3 (20) <0.0001
Anterior Prolift pelvic
floor repair
0 14 (5.8) 2 (2.2) 0
Total Prolift pelvic
floor repair
5 (4.8) 6 (2.5) 0 0
Perineal laceration
repair
0 6 (2.5) 0 0
Urethral reconstruction 0 0 0 3 (20)
Urodynamic parameters
VLPP (cmH2O) 38.8  19.1
(19e100)
71.5  17.5
(30e105)
88.0  16.4
(30e100)
31.3  19.0
(20e50)
<0.0001
MUCP (cmH2O) 31  7.6
(20e40)
45  10
(25e60)
84  25.5
(40e120)
15  4.3
(10e20)
<0.0001
Pelvic organ prolapse
quantification score (cm)
Ba 1.9  1.0 3.2  0.5 2.8  1.3 1  0.8 <0.0001
Bp 2.3  1.0 3.5  0.6 4.0  0.9 2  1.1 <0.0001
C 5.2  3.5 6.7  1.0 7.1  2.8 4  3.2 <0.0001
Data are presented as n (%) or mean  SD.
* Comparison among four surgery groups, significant at p < 0.05.
Ba Z most descendant point of anterior vaginal wall; BMI Z body mass index; Bp Z most descendant point of posterior vaginal wall;
C Z most descendant point of cervix or cuff; MUCP Z maximum urethral closure pressure; PVS Z pubovaginal sling; SD Z standard
deviation; TVT Z tension-free vaginal tape; TVT-O Z tension-free vaginal tape obturator; TVT-S Z tension-free vaginal tape-SECUR;
VLPP Z Valsalva leak-point pressure.
a BMI was calculated from the patients’ height and body weight records.
Table 2 Pre- and postoperative scores on short forms of I-QOL and I-VAS among the four surgery groups.
TVT TVT-O TVT-S PVS p**
Preoperative Postoperative Preoperative Postoperative Preoperative Postoperative Preoperative Postoperative
I-QOL
total
64.1
(61.4, 73.5)
91.6
(84.7, 94.1)*
65.6
(60.2, 71.1)
91.1
(85.3, 95.6)*
70.3
(62.4, 75.5)
92.0
(86.4, 94.9)*
59.1
(53.1, 62.3)
82.8
(75.9, 87.9)*
<0.001
ALB 65.4
(62.9, 79.4)
93.1
(85.6, 95.1)*
64.3
(59.1, 72.5)
93.7
(83.4, 100.0)*
69.2
(61.1, 75.6)
85.6
(81.5, 98.7)*
57.4
(50.1, 70.4)
73.8
(71.2, 93.6)*
<0.001
PS 60.2
(57.1, 70.2)
86.5
(80.2, 95.6)*
70.9
(58.8, 73.2)
85.6
(81.0, 100.0)*
78.1
(70.2, 82.3)
91.7
(84.2, 100.0)*
55.6
(50.2, 64.5)
82.3
(70.5, 87.9)*
<0.001
SE 59.3
(53.2, 66.6)
91.3
(85.7, 100.0)*
61.1
(55.7, 68.3)
94.3
(83.5, 100.0)*
63.8
(60.0, 70.9)
94.2
(85.2, 100.0)*
60.2
(53.3, 68.2)
84.5
(70.0, 92.1)*
<0.001
I-VAS 6.8  2.3 1.3  0.4 6.5  1.6 1.2  0.7 5.8  1.8 1.1  0.4 7.5  2.1 1.4  0.6 <0.001
*p < 0.05, comparison between pre- and postoperative scores in each group, using Wilcoxon signed rank test or paired t test with
Bonferroni correction with a Z 0.013(0.05/4).
**The p values are based on KruskaleWallis test, a comparison between pre- and postoperative scores of four surgery groups.
ManneWhitney tests for multiple comparisons adjusted by Bonferroni test.
ALB Z avoidance and limiting behavior; I-QOL Z Incontinence Quality of Life questionnaire; I-VAS Z Incontinence Visual Analogue
Scale; PS Z psychosocial impacts; SE Z social embarrassment; PVS Z pubovaginal sling; TVT Z tension-free vaginal tape; TVT-
O Z tension-free vaginal tape obturator; TVT-S Z tension-free vaginal tape-SECUR.
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Table 3 Operation-related complications and morbidity in the four groups.
Category TVT TVT-O TVT-S PVS p*
Operative time (min) 46.3  5.8 (30, 50) 31.2  4.9 (25, 45) 7.9  3.2 (7, 15) 101.6  9.5 (90, 150) <0.001
Intraoperative bleeding (mL) 35.4  4.3 (30, 50) 23.2  7.1 (15, 30) 12.0  4.1 (5, 20) 81.2  16.3 (50, 100) <0.001
Catheterization time (d) 2.5  1.1 (1, 4) 2.1  0.8 (1, 3) 1.1  0.6 (1, 2) 10.8  6.4 (5, 49) <0.001
Hospital stay (d) 3.8  2.2 (3, 7) 2.9  1.8 (2, 7) 1.2  0.5 (0.5, 2) 8.4  5.1 (7, 14) <0.001
Operative complications
Bladder perforation 1 (0.95) 0 0 0 <0.001
Hematoma 0 0 0 0
Transfusion 0 0 0 0
Fever 1 (0.95) 0 0 2 (13.33) <0.001
Postoperative de novo urgency 3 (2.86) 5 (2.06) 2 (2.22) 1 (6.67) <0.001
Urinary tract infection 2 (1.90) 1 (0.41) 0 2 (13.33) <0.001
Mesh tape exposure 0 0 0 0
Data are presented as n (%) or mean  SD.
*Comparison among four surgery groups, significant at p < 0.05.
PVSZ pubovaginal sling; SDZ standard deviation; TVTZ tension-free vaginal tape; TVT-OZ tension-free vaginal tape obturator; TVT-
S Z tension-free vaginal tape-SECUR; VLPP Z Valsalva leak-point pressure.
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[15] demonstrated similar cure rates at 12 months in
younger (mean age 57.8 years) and older (mean age 74.9
years) patients who received TVT. In the present study, all
the patients aged >70 years were counseled to undergo the
TVT procedure rather than the TVT-O or TVT-S procedure.
Despite controversy regarding age and its impact on sling
procedure outcomes, age is not a contraindication [16]. If
the patient is young and nulliparous, it is reasonable to
advise her to postpone surgery until after her last preg-
nancy. Moreover, it may be optimal to perform the sling
procedure under local anesthesia with conscious sedation
for an elderly patient with multiple comorbidities.
It is well known that SUI in women is associated with
higher BMI and greater weight [17]. However, the evidence
regarding the role of BMI in the outcomes of sling surgery is
inconsistent [18,19]. One preliminary study has indicated
that TVT is a more effective surgery for SUI compared with
the laparoscopic Burch procedure in obese patients [18].
Nevertheless, BMI has not been investigated as an inde-
pendent variable or risk factor for failure in a randomizedTable 4 Surgical results in patients with TVT, TVT-O, TVT-S, an
Category TVT TVT-O
Success parameters
Cured 96 (91.43)*,**,*** 235 (96.71)**
Improved 6 (5.71)*,** 8 (3.29)***
Failed 3 (2.86)*,**,*** 0**
Subjective satisfaction
Very satisfied 60 (57.14)*,**,*** 154 (63.37)**
Satisfied 34 (32.38)*** 86 (35.39)**
Not satisfied 11 (10.48)*,**,*** 3 (1.23)***
Data are presented as n (%).
* Significantly different compared with TVT-O.
** Significantly different compared with TVT-S.
*** Significantly different compared with PVS.
PVSZ pubovaginal sling; TVTZ tension-free vaginal tape; TVT-OZ t
tape-SECUR; VLPP Z Valsalva leak-point pressure.fashion between two different SUI procedures. Therefore,
no definitive recommendations can be given to patients in
this regard. Our study demonstrated no significant differ-
ence in BMI among the four surgery groups, suggesting that
BMI may not be a risk factor for failure or decreased effi-
cacy following sling procedures. Additional studies,
including prospective randomized trials with longer follow-
up periods, will be required to confirm these findings.
MUI is the coexistence of SUI and urgency urinary in-
continence. Several studies have shown that patients with
MUI may have lower cure rates after surgery than those
with pure SUI [20]. In the present study, the patients with
MUI underwent a trial of medical and behavioral therapy
prior to surgical treatment because one-third of patients
with MUI are expected to become dry with conservative
therapy alone [21]. In this study, for patients with persis-
tent incontinence after a trial of conservative therapy,
surgery was recommended after appropriate patient
counseling. One systematic review including patients with
MUI has reported that the odds of overall subjective cure
are similar for TVT and TVT-O [22]. We were unable tod PVS.
TVT-S PVS p
* 86 (95.56)*** 14 (93.33) <0.001
3 (3.33)*** 1 (6.67) <0.001
1 (1.11)*** 0 <0.001
* 57 (63.33)*** 4 (26.67) <0.001
* 29 (32.22)*** 11 (73.33) <0.001
4 (4.44)*** 0 <0.001
ension-free vaginal tape obturator; TVT-SZ tension-free vaginal
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the current study because patients in each sling group were
significantly different in terms of preoperative de-
mographics. However, in patients with MUI symptoms, we
would like to recommend TVT-O, as our data demonstrate
that TVT-O has the lowest rate of postoperative de novo
urgency (2.06%) compared with the other three sling pro-
cedures. In addition to our observation, one study has
suggested that the transobturator approach has a lower
rate of postoperative urgency and urge incontinence than
the retropubic approach [3].
In all major national and international guidelines from
both gynecological and urological scientific societies, uro-
dynamic testing is advised to be performed prior to invasive
treatment for SUI. Even then, the extent to which urody-
namic evaluation impacts the choice or outcome of surgery
remains controversial [23]. Some studies have indicated
that women with reduced maximum urethral closure pres-
sures (MUCPs) have poorer outcomes after surgery [24] and
suggested that women with low closure pressures may
benefit from a more obstructive type of surgery. In this
study, the mean MUCP was 31  7.6 cmH2O (range, 20e40
cmH2O) in the TVT group, 45  10 cmH2O (range, 25e60
cmH2O) in the TVT-O group, 84  25.5 cmH2O (range,
40e120 cmH2O) in the TVT-S group, and 15  4.3 cmH2O
(range, 10e20 cmH2O) in the PVS group (Table 1). SUI pa-
tients who underwent TVT or PVS demonstrated a Valsalva
leak point pressure (VLPP) of less than 60 cmH2O. For those
who underwent TVT-O or TVT-S, the VLPP was greater than
60 cmH2O (Table 1). Other data indicate that preoperative
VLPP has no bearing on outcomes after treatment for SUI
using a sling procedure [25]. However, it has been sug-
gested that patients who demonstrate a low leak point
pressure (<60 cmH2O) or low MUCP (<20 cmH2O) are
associated with a higher risk of surgical failure with the
TVT-O approach compared with the PVS or TVT approach
[26], and our data demonstrated a patient cure rate of 100%
(15/15) for the PVS group. Therefore, with all other factors
being equal, it is reasonable to treat patients with intrinsic
sphincter deficiency using PVS, which is more obstructive.
However, some authors suggest that patients with lower
MUCPs have better outcomes with the retropubic approach
(TVT) [27].
Whether a concomitant SUI procedure should be per-
formed in all, some, or no patients undergoing POP repair is
under debate. However, Lee et al. [28] have recently
reviewed the literature about the efficacy and safety of
using sling procedures for patients with SUI who are also
undergoing prolapse repair. Their review suggested that
TVT, TVT-O, and PVS are effective and safe for the treat-
ment of SUI with concurrent prolapse repair, with no dif-
ference in the expected cure rate compared with patients
with isolated SUI. Therefore, in women with SUI (who
demonstrated a positive stress test) who underwent POP
surgery, we performed the sling procedure concurrent with
the POP surgery, and we believe that TVT-O is often
preferable.
Given the complex, multifactorial pathophysiology of
SUI and the spectrum of severity, it is unlikely that any
single operation currently utilized will be applicable to all
patients with SUI and will be accepted as such universally
[29]. However, some factors must be considered to guidethe choice of surgical procedure for the treatment of SUI in
individual patients [30], even though the evidence sup-
porting the effects of these factors is generally weak.
Moreover, the surgical choice of sling procedure may also
be dependent on the surgical experience of a surgeon and
the patient’s preference. As such, these factors should be
used for patient counseling to ensure that the benefits
outweigh any possible complications and that the patient
goes home and remains satisfied with the procedure [29].
In conclusion, sling procedures (TVT, TVT-O, TVT-S, and
PVS) are safe and reproducibly effective. However, no
single sling procedure is universally successful for any of
the different conditions associated with SUI. To maximize
success and minimize the risk of complications, factors such
as age, incontinence type, urodynamic parameters, per-
sonal experience, and preferences of the surgeon and pa-
tient should be considered when choosing a suitable sling
procedure for an individual patient with SUI.
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